10 Trending AI Stocks on Latest News and Ratings

Page 7 of 10

4. Guardant Health, Inc. (NASDAQ:GH)

Number of Hedge Fund Holders: 28

Guardant Health, Inc. (NASDAQ:GH) is a leading precision oncology company offering critical insights for cancer detection and treatment through advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. On January 16, the company announced that it had entered into a collaboration with ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company. The collaboration has allowed the companies to come up with a data solution integrating comprehensive patient electronic medical record (EMR) data with detailed tumor profiling information. The joint RWD solution will allow biopharma collaborators to interpret disease biology in an enhanced manner as well as identify the causes and timing of tumor evolution and the intrinsic and acquired resistance mechanisms involved. Through the use of advanced data and AI tools, the collaboration aims to improve cancer treatment and help design better clinical trials.

“Realizing the potential of precision medicine requires a comprehensive, multi-dimensional understanding of the tumor, the clinical environment and the patient’s response to therapy. This partnership between Guardant and ConcertAI gives evidence and outcomes researchers access to extensive, robust data and AI-based modeling that can provide unprecedented insight into a patient’s cancer journey, including a tumor’s complex systemic interactions, to help them accelerate the development of much-needed cancer therapies. It represents another milestone in Guardant’s mission to conquer cancer with data”.

-Helmy Eltoukhy, Guardant Health co-CEO.

Page 7 of 10